newsfilter
← Latest News
GlobeNewswire·

Panbela Announces Pricing of Approximately $8.5 Million Public Offering

MINNEAPOLIS, June 16, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today